16_HST110 Introduction to Renal Disease II - CKD 2017 Flashcards
What % of adults in the US have CKD?
9-13%
Patients with CKD and ESRD have a higher risk of mortality, particularly from cardiovascular disease
Survival of patients on dialysis is (X)% at one year, (Y)% at five years
X = 81% Y = 34%
What are the 2 NKF-K/DOQI definitions of CKD?
Presence of markers of kidney damage for 3 or more months
(Structural or functional abnormalities (pathology, imaging, blood or urine tests) with or without decreased GFR)
OR
Presence of GFR <60 mL/min/1.73m^2 for 3 or more months with or without other signs of kidney damage
In Stage 1 CKD, GFR >90 (Kidney damage with normal or high GFR), what is the necessary action?
Diagnosis and treatment
Treatment of comorbid conditions
Slowing progression
CVD risk reduction
In Stage 2 CKD, GFR 60-89 (Kidney damage with mild decrease in GFR), what is the necessary action?
Estimating progression
In Stage 3 CKD, GFR 30-59 (Moderately decresed GFR), what is the necessary action?
Evaluating and treating complications
In Stage 4 CKD, GFR 15-29 (Severe decrease in GFR), what is the necessary action?
Preparation for kidney replacement therapy
In Stage 5 CKD, GFR <15 or dialysis (Kidney failure), what is the necessary action?
Replacement (if uremia present)
What are the most common causes of ESRD?
Diabetes (44%)
Hypertension (28%)
Glomerulonephritis (6%)
Cystic kidney disease (2%)
What 2 conditions account for most cases of non-ESRD CKD?
Hypertension and diabetes
What are the 3 general methods CKD develops?
Progressive disease (e.g. diabetes)
Repeated episodes of kidney injury
Secondary disease-independent functional, structural, and metabolic adaptations
What are 4 experimental consequences of a 5/6 nephrectomy in rat models?
Renal compensatory hypertrophy and functional adaptation occur
Glomerular sclerosis develops and progresses
Hypertension develops
Rats eventually develop ESRD within 4-6 months
Increases in P_GC due to kidney injury and compensation by remaining nephrons leads to podocyte injury and loss, ___ and ____
Effacement, Detachment
Sclerotic area formation in damaged kidneys (glomerulus) lead to what 2 conditions?
Glomerulosclerosis and hyalinosis (with obliteration of capillary loops)
Podocyte effacement and detachment breaks a critical barrier in proper filtrate formation. What condition can result?
Proteinuria
Nephron damage can lead to tubulointerstitial changes leading to what 2 conditions?
Interstitial fibrosis
Tubular atrophy
Progression of chronic kidney disease can be prevented by reversing the intraglomerular (X) and (Y) as well as the (Z) due to the increased local convection
X = Hypertension (Antihypertensive therapy) Y = Hypertrophy Z = Proteinuria (Dietary protein restriction)
GFR varies directly with dietary protein intake
GFR can acutely rise by (X)% after a eating a protein load
X = 15-40
In remnant model rats, a low protein diet can do what 3 things?
Prevent intraglomerular hypertension and hypertrophy
Decrease proteinuria
Prevent glomerulosclerosis
Intraglomerular pressure can be lowered by lowering (X) blood pressure with medications
Effectiveness and degree of renal protection depends on the class of anti-hypertensive drug used
X = systemic
Angiotensin II inhibition as an antihypertensive therapy is effective due to the decrease in (X) resistance
X = efferent
ACE inhibitors such as (X) are also effective at decreasing proteinuria and glomerulosclerosis
X = Enalapril
ACE inhibitors and ARBs are renoprotective in rats, decreasing what 4 conditions and increasing kidney survival?
Systemic blood pressure, intraglomerular pressure, proteinuria, glomerulosclerosis
Dietary protein restriction may protect against the progression of CKD in humans by reducing (X) pressure
Benefits of dietary protein restriction to (Y) g/kg per day on CKD progression is controversial. At best, a small reduction in the rate of GFR decline can be observed with low protein diet
X = intraglomerular Y = 0.6-0.8
Loss of nephrons leads to compensatory (X) and (Y) of surviving nephrons to maintain GFR. These changes over long periods of time result in focal and segmental (Z) (scarring in parts of some but not all glomeruli)
X = hypertrophy Y = hyperfiltration Z = glomerulosclerosis
Antihypertensive treatment with (X) or (Y) have been shown in animals and humans to be renoprotective by lowering intraglomerular pressure
X = ACE inhibitors Y = ARBs
Uremia is a constellation of signs and symptoms that appear in the setting of _____ renal disease
X = advanced
Name some of the 8 categories of systems affected in uremia
Musculoskeletal, Hematologic, Electrolytes, Neurologic, Dermatologic, Cardiopulmonary, Endocrine, Gastrointestinal
What 3 conditions (decreases in secretion or excretion) are involved in the pathogenesis of uremia?
Decreased excretion of electrolytes and water
Decreased excretion of organic solutes (uremic toxins)
Decreased renal hormone synthesis
What are the 3 categories of uremic toxins?
Small, water-soluble
Small, lipid-soluble and/or protein-bound
Middle molecules (larger)
Name at least 2 examples of small, water-soluble uremic toxins
Urea, guanidines, oxalate, phosphate, polyamines
Name at least 3 examples of small, lipid-soluble and/or protein-bound uremic toxins
P-cresol, p-cresyl sulfate, homocysteine, indoles
Name at least 1 example of a middle molecule (larger) uremic toxin
β2-microglobulin, PTH, AGEs
Patients typically do not complain of common signs and symptoms of uremia (nausea, vomiting, fatigue, anorexia, weight loss, muscle cramps, pruritus, mental status changes, visual disturbances, increased thirst, and bleeding) until GFR falls below (X) mL/min (10% normal)
X = 10-15